On September 14, 2009, Bayer AG’s Supervisory Board appointed the company’s future management line-up. Werner Wenning, Bayer AG CEO since 2002, announced his decision to extend his contract of service by 8 months to September 30, 2010. The Supervisory Board appointed Dr. Marijn E. Dekkers to succeed Wenning as CEO, effective October 1, 2010. Dekkers is currently the president and CEO of Thermo Fisher Scientific Inc.
Dekkers will join the Bayer Management Board on January 1, 2010, and, in a transition phase, will also serve as CEO of Bayer HealthCare, succeeding Arthur J. Higgins. Higgins, who has decided to leave the company during the first half of 2010, was appointed Chairman of the Bayer HealthCare Executive Committee on July 1, 2004, and has been CEO of Bayer HealthCare AG since January 1, 2006.
CFO Klaus Kühn plans to take an early retirement following the Annual Stockholders’ Meeting on April 30, 2010. The Supervisory Board has appointed Werner Baumann, currently a member of the Board of Management and Executive Committee of Bayer HealthCare, to be Kühn’s successor. Baumann will also join the Bayer Management Board on January 1, 2010.
Bayer AG is headquartered in Leverkusen, Germany. U.S.-based Thermo Fisher Scientific is headquartered in Waltham, MA.